Search results
Results from the WOW.Com Content Network
Pantoprazole, sold under the brand name Protonix, among others, is a medication used for the treatment of stomach ulcers, short-term treatment of erosive esophagitis due to gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions including Zollinger–Ellison syndrome.
Nirmatrelvir belongs to a family of 3C-like protease inhibitors developed in the late 2010s against feline coronavirus, while ritonavir is an antiretroviral drug developed in the 1980s and used since the 1990s to inhibit the enzyme that metabolizes other protease inhibitors.
Specialty professional organizations recommend that people take the lowest effective PPI dose to achieve the desired therapeutic result when used to treat gastroesophageal reflux disease long-term. [ 20 ] [ 21 ] [ 22 ] In the United States, the Food and Drug Administration (FDA) has advised that over-the-counter PPIs, such as Prilosec OTC ...
The drug is no longer recommended for use as a COVID treatment by major public health and medical organizations. Journal pulls scientific paper that popularized hydroxychloroquine as COVID-19 ...
The flu is ramping up after a slow start to the season. Positive tests rose 12% for the week ending Dec. 21, compared to the week prior, according to data released Friday by the Centers for ...
Pantoprazole was first prepared in April 1985 by a small group of scale-up chemists. It is a dimethoxy-substituted pyridine bound to a fluoroalkoxy substituted benzimidazole. [5] Pantoprazole sodium is available as gastroresistant or delayed release tablets and as lyophilized powder for intravenous use.
Teacher, Driving Home From Work, Pulls Over To Save Choking 100-Year-old Woman With Heimlich Maneuver Wrap your arms around their torso from the back. Make a fist with one hand and grab it with ...
Since the introduction of multi-drug therapy in 1981, the prevalence of leprosy has been reduced by over 95%. [ 144 ] [ 145 ] The success of the treatment has prompted the WHO in 1991 to set a target of less than one case per 10,000 people (eliminate the disease as a public health risk) which was achieved in 2000. [ 144 ]